Our strategy

Our alliances enable us to deliver sustained growth and value.

Our strategic priorities

To enable the successful delivery of our new strategy, we have identified four priorities for the business over the next three to five years:

We focus on fitting treatments to patients: providing the right therapy for the right patient to ensure the best response at the right time for the right value. Our approach combines our rich expertise in pharmaceuticals and diagnostics with expanded data science capabilities to drive more effective and efficient research and enable better therapeutic decisions for patients.
Working in partnership with third parties, we are better positioned to offer integrated solutions that improve medical and health outcomes. We work with stakeholders across the healthcare ecosystem to broaden access to our solutions for people who need them.

Additionally, we are passionate about advancing science, regardless of where it comes from, by identifying the best innovations, whether internal and external.
Our pursuit of excellence in science rests on four key elements: an exceptionally broad and deep understanding of disease biology; the seamless integration of our capabilities in pharmaceuticals and diagnostics; a diversity of approaches to maximise innovation; and a long-term vision